tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BPMC Stock Latest News

Optimistic Long-Term Growth Potential for Blueprint Medicines Amid Short-Term Revenue Concerns
RatingsOptimistic Long-Term Growth Potential for Blueprint Medicines Amid Short-Term Revenue Concerns
2d ago
BPMC
JPMorgan healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
7d ago
BPMC
COGT
JPMorgan healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
7d ago
BPMC
COGT
Blueprint Medicines: Strong Growth, Strategic M&A Potential, and Promising Pipeline Drive Positive Outlook
PremiumRatings
Blueprint Medicines: Strong Growth, Strategic M&A Potential, and Promising Pipeline Drive Positive Outlook
11d ago
BPMC
Blueprint Medicines assumed with an Equal Weight at Morgan Stanley
PremiumThe Fly
Blueprint Medicines assumed with an Equal Weight at Morgan Stanley
13d ago
BPMC
Balanced Outlook on Blueprint Medicines: Growth Prospects and Market Dynamics
PremiumRatingsBalanced Outlook on Blueprint Medicines: Growth Prospects and Market Dynamics
13d ago
BPMC
Blueprint Medicines assumed with an Equal Weight at Morgan Stanley
Premium
The Fly
Blueprint Medicines assumed with an Equal Weight at Morgan Stanley
13d ago
BPMC
Coinbase initiated, Block upgraded: Wall Street’s top analyst calls
Premium
The Fly
Coinbase initiated, Block upgraded: Wall Street’s top analyst calls
14d ago
BE
RL
Wolfe Research starts Blueprint Medicines at Outperform on bullish Ayvakit view
PremiumThe Fly
Wolfe Research starts Blueprint Medicines at Outperform on bullish Ayvakit view
15d ago
BPMC
COGT
Blueprint Medicines initiated with an Outperform at Wolfe Research
PremiumThe Fly
Blueprint Medicines initiated with an Outperform at Wolfe Research
15d ago
BPMC
Reddit initiated, Netflix upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Reddit initiated, Netflix upgraded: Wall Street’s top analyst calls
15d ago
BX
ACN
Blueprint Medicines initiated with a Buy at Jefferies
PremiumThe Fly
Blueprint Medicines initiated with a Buy at Jefferies
16d ago
BPMC
Tesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
PremiumThe FlyTesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
25d ago
W
AL
Blueprint Medicines initiated with an Outperform at Scotiabank
Premium
The Fly
Blueprint Medicines initiated with an Outperform at Scotiabank
25d ago
BPMC
Blueprint Medicines: Hold Rating Amid Concerns Over Ayvakit’s Liver Function Test Elevations
Premium
Ratings
Blueprint Medicines: Hold Rating Amid Concerns Over Ayvakit’s Liver Function Test Elevations
28d ago
BPMC
Cautious Optimism: Hold Rating Given to Blueprint Medicines Amid Financial Performance Concerns and Slower Ayvakit Growth Projections
PremiumRatings
Cautious Optimism: Hold Rating Given to Blueprint Medicines Amid Financial Performance Concerns and Slower Ayvakit Growth Projections
1M ago
BPMC
Blueprint Medicines price target raised to $135 from $127 at Baird
PremiumThe Fly
Blueprint Medicines price target raised to $135 from $127 at Baird
2M ago
BPMC
Strong Buy Rating for Blueprint Medicines: Ayvakit’s Growth Potential and Market Opportunities
PremiumRatings
Strong Buy Rating for Blueprint Medicines: Ayvakit’s Growth Potential and Market Opportunities
2M ago
BPMC
Blueprint Medicines Reports Strong Growth and Promising Outlook
PremiumCompany Announcements
Blueprint Medicines Reports Strong Growth and Promising Outlook
2M ago
BPMC
Blueprint Medicines: Positive Earnings Call Highlights Growth
PremiumCompany AnnouncementsBlueprint Medicines: Positive Earnings Call Highlights Growth
2M ago
BPMC
Strong Market Position and Growth Potential Drive Buy Rating for Blueprint Medicines
Premium
Ratings
Strong Market Position and Growth Potential Drive Buy Rating for Blueprint Medicines
2M ago
BPMC
Blueprint Medicines should be bought on any weakness, says Stifel
Premium
The Fly
Blueprint Medicines should be bought on any weakness, says Stifel
2M ago
BPMC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >